A detailed history of Abn Amro Investment Solutions transactions in Abb Vie Inc. stock. As of the latest transaction made, Abn Amro Investment Solutions holds 67,864 shares of ABBV stock, worth $15.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
67,864
Holding current value
$15.9 Million
% of portfolio
0.25%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$170.16 - $206.27 $11.5 Million - $14 Million
67,864 New
67,864 $12.6 Billion
Q1 2025

Aug 27, 2025

BUY
$169.2 - $216.66 $1.04 Million - $1.34 Million
6,171 Added 9.09%
74,035 $15.5 Billion
Q4 2024

Sep 04, 2025

SELL
$164.99 - $203.87 $1.94 Million - $2.39 Million
-11,741 Reduced 7.04%
154,927 $27.5 Billion
Q3 2024

Sep 04, 2025

BUY
$163.84 - $199.33 $16.2 Million - $19.7 Million
98,804 Added 145.59%
166,668 $32.9 Billion
Q2 2024

Sep 04, 2025

BUY
$154.79 - $180.76 $13.4 Million - $15.6 Million
86,552 Added 127.54%
154,416 $26.5 Billion
Q1 2024

Sep 05, 2025

BUY
$159.82 - $182.1 $23.4 Million - $26.7 Million
146,647 Added 1807.78%
154,759 $28.2 Billion
Q4 2023

Sep 05, 2025

SELL
$137.6 - $154.97 $32,198 - $36,262
-234 Reduced 2.8%
8,112 $1.26 Billion
Q3 2023

Sep 05, 2025

BUY
$133.59 - $154.65 $139,467 - $161,454
1,044 Added 14.3%
8,346 $1.24 Billion
Q2 2023

Sep 05, 2025

SELL
$132.51 - $164.9 $379,641 - $472,438
-2,865 Reduced 28.18%
7,302 $984 Million
Q1 2023

Sep 05, 2025

SELL
$144.61 - $166.54 $8.34 Million - $9.61 Million
-57,697 Reduced 85.02%
10,167 $1.62 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Abn Amro Investment Solutions Portfolio

Follow Abn Amro Investment Solutions and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Investment Solutions with notifications on news.